Strategic exits SPE Capital recently exited assets to Amethis in March 2026, indicating potential readiness to partner on secondary-like opportunities, fund liquidity events, or co-investment exits with stakeholders looking for strategic momentum.

Growth equity footprint Active deployment in growth equity across healthcare, education, business services, and manufacturing in Europe, Africa, and the Middle East suggests opportunities to align with funds or managers seeking co‑investments or GP-led growth strategies in these sectors.

Regional breadth Offices across Abidjan, Cairo, Casablanca, Paris and Tunis and coverage of 30 markets highlight a regional know‑how that can be leveraged for cross‑border deal sourcing, advisory partnerships, and regional fund-raising support for third‑party managers.

Recent investments Recent portfolio moves include OrchidiaPharma, Chari, Delta Holdings, Dislog Group, and Tamweely Microfinance, signaling a diversified appetite and potential for follow-on round syndications, co‑investments, and advisory mandates to scale these platforms.

Financial health Revenue range of 10–25 million USD and a mid-sized team (11–50 employees) indicate a stable mid-market investment shop that may be open to structured financing products, strategic partnerships, and revenue‑based financing collaborations with capital providers and portfolio companies.